Biogen sells equity stake in its biosimilar JV with Samsung Biologics for US $ 2.3 billion
The companies will continue with their exclusive agreements, including commercialization of their current portfolio
The companies will continue with their exclusive agreements, including commercialization of their current portfolio
Chicago based virtual reality company reaches AIIMS, assisting in surgical planning and training
After double lung transplantation, he was discharged without supplemental oxygen on the eleventh day
The latest research results indicated that JMB2002 had high binding activity to the Omicron variant and showed potent Omicron pseudovirus neutralization function
The surgery was helmed by Prof. Dr. Vishwanath Pai, Sr. Consultant, Department of Minimally Invasive Surgery, Prashanth Hospitals, Velachery
Sputnik Light as a booster significantly increases virus-neutralizing activity against Omicron based on sera 2-3 months after revaccination and is a universal booster to other vaccines inducing stronger antibody and T-cell response
The company will collaborate with U.S.-based colleagues to help life sciences companies improve commercial effectiveness
The company will manufacture a cancer immunotherapy product from 2022
The company will donate 5000 nebulizers to primary health care centres in rural India
The setting up of these 8 plants will lead to a total committed investment of Rs. 260.40 crore
Subscribe To Our Newsletter & Stay Updated